Please assess the completion status of the following clinical trial:

Trial Title: Does Vitamin D Improve Glycemic Control in Type II DM?

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Type II diabetics living in Riyadh area who consume no more than one serving of milk/day~* Do not take vitamin supplement~* Habitually have less than 10 hour of sun exposure per week~* Don't suffer from granulomatous conditions, liver disease, or kidney disease~* Don't take anticonvulsants, barbiturates, or steroids.~* Stable glycemic control (not more than 0.5% difference between current HA1c and a HA1c obtained 2-4 months earlier)~* Current HA1c between 6.5 and 8%, and current total 25 OH vitamin D level between 10-30 nmol/L.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- vitamin D3 2000 IU (Type: EXPERIMENTAL): None
- vitamin D3 5000 IU (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).